BROOKE MOORE: Open Payments
NPI 1043791635 · BRYAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 64 payments from 13 companies in 2025. Trend: 2023 $337 · 2024 $804 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $242 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $165 |
| Janssen Biotech, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Phathom Pharmaceuticals, Inc. | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| Madrigal Pharmaceuticals | 2 | $56 |
| GENZYME CORPORATION | 2 | $53 |
| Ardelyx, Inc. | 2 | $41 |
| Celltrion USA Inc. | 2 | $34 |
Products named: XIFAXAN, DUPIXENT, TREMFYA, VOQUEZNA, LINZESS, RINVOQ, REZDIFFRA, EOHILIA.
Industry payments across OH — which companies pay providers there.
